vaccin
indispens
tool
fight
diseas
signific
impact
public
health
sever
tradit
vaccin
reli
use
inactiv
form
pathogen
induc
protect
immun
respons
howev
case
malaria
pathogen
difficult
cultur
vitro
larg
scale
moreov
use
whole
organ
vaccin
introduc
high
antigen
load
often
small
subset
antigen
drive
also
possibl
advers
allergen
reaction
certain
antigen
prepar
obstacl
led
increas
interest
subunit
vaccin
singl
select
protein
use
vaccin
formul
induc
protect
use
peptid
vaccin
take
rational
even
singl
protein
antigen
may
mani
epitop
contribut
protect
immun
peptid
vaccin
offer
mean
formul
vaccin
contain
epitop
capabl
induc
posit
effici
immun
eas
peptid
synthesi
make
larg
scale
product
feasibl
whilst
also
offer
cleaner
vaccin
prepar
lack
biolog
contamin
commonli
associ
recombin
express
whole
organ
vaccin
specif
peptid
also
allow
improv
customis
facilit
exampl
multiepitop
approach
target
differ
strain
stage
life
cycl
pathogen
reason
interest
area
vaccin
design
peptid
vaccin
reach
clinic
trial
target
wide
rang
indic
tabl
seven
vaccin
reach
phase
iii
trial
tabl
much
recent
interest
focuss
epitop
vaccin
reach
phase
iii
base
mani
diseas
howev
respons
also
play
import
role
immun
protect
vaccin
base
epitop
prove
challeng
number
reason
owe
small
size
peptid
gener
poorli
immunogen
addit
epitop
requir
establish
robust
immun
respons
may
also
absent
smaller
peptid
address
issu
carrier
protein
adjuv
typic
includ
vaccin
formul
peptid
also
prone
enzymat
degrad
combat
epitop
modifi
conform
stabil
cyclis
peptid
mimet
resist
proteolysi
final
perhap
importantli
approach
limit
antibodi
respons
mani
protein
antigen
domin
conform
epitop
difficult
imposs
captur
effect
design
review
argu
intrins
disord
protein
antigen
lack
order
structur
repres
excel
start
point
develop
peptid
vaccin
argument
structur
follow
first
establish
disord
protein
repres
import
class
antigen
wide
rang
human
pathogen
second
describ
uniqu
featur
antigen
interact
antibodi
highlight
properti
render
particularli
suit
develop
peptid
vaccin
particular
note
disord
epitop
appear
invari
linear
epitop
challeng
captur
conform
epitop
peptid
vaccin
may
appli
outlin
opportun
challeng
present
approach
vaccin
develop
exemplifi
effort
develop
vaccin
base
disord
malaria
antigen
final
specul
futur
develop
within
peptid
scienc
beyond
fulli
enabl
promis
approach
realiz
intrins
disord
protein
found
throughout
particularli
enrich
context
molecular
signal
regulatori
consist
regulatori
role
extent
disord
within
proteom
individu
speci
tend
increas
environment
complex
organ
thu
organ
live
divers
highli
variabl
environ
tend
highli
disord
proteom
reflect
need
sophist
regulatori
mechan
surviv
environment
divers
result
disord
protein
particularli
abund
rang
pathogen
organ
must
surviv
divers
often
hostil
host
environ
context
disord
protein
play
import
role
accordingli
disord
protein
often
expos
host
immun
even
amongst
bacteria
significantli
order
proteom
eukaryot
speci
mani
protein
involv
pathogen
effector
mechan
appear
often
assum
disord
antigen
imped
develop
effect
immun
respons
henc
abund
repres
adapt
mechan
enabl
pathogen
evad
immun
mechan
propos
account
immun
evas
divers
contest
critic
assess
sever
mechan
section
despit
fact
hypothes
receiv
limit
direct
experiment
support
underli
assumpt
repetit
disord
antigen
fail
elicit
effect
antibodi
respons
continu
enjoy
signific
howev
recent
sequenc
genom
sever
speci
parasit
demonstr
disord
sequenc
unusu
abund
wide
rang
gene
includ
mani
appear
antigen
suggest
presenc
sequenc
parasit
primarili
strategi
evad
host
immun
respons
prompt
signific
debat
surround
mechan
respons
gener
maintain
abund
fact
seem
like
distinct
class
sequenc
exist
within
parasit
genom
suggest
divers
contributori
note
abund
disord
sequenc
plasmodium
speci
respons
malaria
relat
parasit
first
identifi
analysi
antigen
import
protein
surpris
substanti
fraction
malaria
vaccin
candid
contain
region
disord
region
often
import
target
antibodi
promin
exampl
circumsporozoit
protein
csp
domin
antigen
surfac
sporozoit
parasit
form
inject
host
mosquito
must
replic
within
host
hepatocyt
prior
establish
symptomat
csp
extens
studi
antigen
inclus
malaria
vaccin
vaccin
rt
includ
half
csp
fuse
hepat
b
assembl
rt
antigen
includ
thrombospondin
repeat
domain
csp
although
clear
domain
correctli
fold
vaccin
rest
csp
predict
disord
predict
confirm
experiment
repeat
csp
appear
immunodomin
target
protect
antibodi
induc
rt
second
import
malaria
vaccin
candid
entir
disord
merozoit
surfac
protein
antibodi
target
aris
cours
malaria
infect
presenc
antibodi
correl
protect
subsequ
also
induc
robust
antibodi
respons
use
vaccin
respons
shown
mediat
protect
phase
iib
trial
papua
new
conform
antigen
properti
subject
extens
provid
import
insight
interplay
antigen
disord
return
section
mani
addit
antigen
signific
interest
vaccin
candid
malaria
diseas
known
predict
disord
highlight
number
exampl
tabl
appar
howev
mani
case
disord
natur
antigen
wide
appreci
rais
possibl
mani
import
antigen
yet
recogn
disord
preced
discuss
establish
disord
protein
import
antigen
broad
rang
immunolog
context
would
natur
suppos
antibodi
abl
effect
recogn
disord
antigen
hand
also
allud
number
argument
suggest
antibodi
respons
disord
antigen
dysfunct
even
address
appar
contradict
recent
assembl
larg
protein
antigen
immun
epitop
databas
iedb
epitop
aris
protein
region
predict
disord
well
repres
dataset
fact
found
posit
correl
predict
disord
likelihood
put
epitop
test
posit
antibodi
bind
assay
report
iedb
establish
disord
impedi
effect
antibodi
recognit
figur
other
recent
made
observ
extend
show
predictor
protein
disord
dedic
predictor
identif
may
reflect
fact
residu
score
highli
disord
predictor
like
solvent
exposur
prerequisit
establish
predictor
argu
disord
antigen
may
imped
develop
effect
immun
respons
interf
process
matur
differenti
memori
antibodi
produc
process
matur
antibodi
undergo
somat
hypermut
select
antigen
bind
affin
matur
essenti
develop
antibodi
respons
affin
matur
antibodi
disord
antigen
significantli
imped
would
expect
antibodi
fewer
mutat
respect
germlin
antibodi
sequenc
antibodi
order
antigen
fact
compar
avail
antibodi
sequenc
correspond
germlin
sequenc
detect
differ
number
mutat
two
class
antibodi
figur
impli
affin
matur
proce
equival
efficaci
antibodi
order
disord
highli
repetit
antigen
capabl
elicit
respons
independ
help
normal
requir
matur
respons
character
defect
affin
matur
failur
establish
convent
memori
propos
one
reason
repetit
disord
antigen
may
fail
inde
repetit
malaria
antigen
csp
induc
respons
absenc
help
respons
much
weaker
transient
presenc
thu
normal
respons
prototyp
repetit
antigen
addit
specif
evid
affin
matur
antibodi
target
epitop
come
recent
studi
antibodi
respons
induc
clinic
trial
rt
context
natur
studi
establish
presenc
extens
somat
antibodi
respons
respons
influenc
strongli
vaccin
schedul
correl
antibodi
avid
confirm
affin
matur
effect
context
clear
presenc
transient
independ
respons
repetit
disord
antigen
csp
preclud
develop
classic
depend
respons
accompani
affin
matur
basi
misconcept
disord
protein
poorli
recogn
antibodi
aris
fact
disord
epitop
definit
fail
adopt
singl
conform
context
nativ
protein
might
recogn
antibodi
clear
howev
disord
protein
capabl
recogn
protein
bind
partner
antibodi
otherwis
achiev
disord
protein
often
undergo
process
coupl
fold
bind
bind
partner
act
effect
templat
disord
protein
fold
rel
bound
nonetheless
coupl
fold
bind
place
kinet
thermodynam
constraint
particular
signific
entrop
cost
fold
reduc
overal
bind
affin
interact
unless
cost
offset
thu
interact
disord
protein
often
rel
low
affin
despit
maintain
high
specif
properti
ideal
suit
mediat
signal
must
switch
rapidli
account
enrich
disord
protein
involv
signal
transduct
interact
quit
distinct
howev
typic
interact
select
high
affin
slow
dissoci
consider
rais
possibl
antibodi
recogn
disord
antigen
may
reduc
affin
reflect
substanti
entrop
cost
must
accompani
disord
antigen
adopt
singl
fact
use
dataset
order
disord
epitop
iedb
shown
disord
account
littl
wide
variat
observ
affin
antibodi
protein
specif
observ
approxim
differ
median
affin
antibodi
recogn
order
epitop
recogn
disord
epitop
loss
affin
much
smaller
might
expect
basi
expect
entrop
cost
coupl
fold
bind
figur
investig
structur
basi
rel
high
affin
antibodi
recogn
disord
antigen
dataset
order
disord
antigen
protein
databank
pdb
result
set
structur
complex
repres
disord
comparison
structur
reveal
disord
epitop
involv
substanti
fewer
residu
order
epitop
perhap
mean
minim
entrop
cost
bind
figur
thu
disord
epitop
rare
span
residu
antigen
primari
sequenc
major
residu
make
direct
interact
antibodi
structur
observ
consist
epitop
map
experi
larg
number
antibodi
sever
disord
impli
disord
epitop
overwhelmingli
linear
epitop
antibodi
recognit
determin
larg
local
antigen
sequenc
stand
contrast
convent
order
antigen
larg
fraction
antibodi
respons
typic
direct
conform
epitop
implic
reduct
size
disord
epitop
disord
epitop
much
effici
order
epitop
interact
antibodi
sens
achiev
bind
free
energi
per
unit
interact
surfac
area
per
epitop
comparison
structur
order
disord
antigen
reveal
number
featur
interact
may
contribut
effici
includ
concav
antigen
bind
site
better
complementar
shape
antigen
well
increas
number
per
epitop
residu
structur
featur
impli
antibodi
disord
epitop
better
match
bound
conform
epitop
antibodi
order
epitop
like
reflect
extent
abil
disord
epitop
adapt
bind
site
antibodi
inde
flexibl
permit
disord
epitop
adopt
distinct
conform
bound
differ
nonetheless
exquisit
complementar
also
like
requir
adapt
part
may
also
seen
evid
support
conclus
affin
matur
antibodi
disord
epitop
least
effect
affin
matur
target
order
epitop
although
studi
describ
establish
disord
impedi
develop
robust
antibodi
respons
interplay
disord
antigen
may
complic
level
singl
antigen
studi
compar
experiment
measur
conform
disord
deriv
nmr
relax
rate
observ
pattern
antigen
infer
experiment
immun
anim
result
studi
contrast
bioinformat
neg
correl
antigen
disord
flexibl
region
least
like
recogn
antibodi
sera
region
show
slight
conform
restrict
appar
domin
antibodi
respons
immun
import
note
experiment
measur
disord
use
studi
correl
poorli
disord
predict
score
use
bioinformat
analysi
reflect
uniformli
high
level
disord
across
residu
iupr
score
inde
flexibl
region
extrem
disord
compos
exclus
small
amino
acid
gli
ser
ala
thu
may
extrem
level
disord
attend
low
sequenc
complex
suffici
significantli
imped
develop
strong
antibodi
respons
wherea
level
disord
typic
encount
disord
antigen
compat
robust
respons
outlin
importantli
flexibl
dynam
region
also
polymorph
region
antigen
togeth
low
sequenc
complex
render
unattract
target
vaccin
develop
greater
immunogen
disord
less
flexibl
region
protein
like
advantag
context
vaccin
develop
moreov
key
advantag
afford
approach
vaccin
develop
abil
omit
ineffect
region
polymorph
region
entir
ensur
respons
focus
conserv
epitop
like
elicit
broadli
protect
respons
exemplifi
long
synthet
peptid
deriv
half
consid
potenti
compon
malaria
peptid
includ
conserv
dimorph
sequenc
exclud
highli
polymorph
region
beyond
specif
immedi
interact
broader
context
antibodi
encount
antigen
like
influenc
way
antibodi
abl
recogn
disord
antigen
effect
case
order
antigen
aris
exampl
molecular
interact
lead
conform
chang
mask
disrupt
epitop
otherwis
render
similar
effect
like
disord
antigen
inde
conform
properti
disord
protein
uniqu
sensit
modul
interact
modif
mechan
antibodi
recognit
disord
epitop
may
expect
particularli
sensit
context
antibodi
recogn
exampl
seen
mask
conserv
epitop
amongst
panel
monoclon
mous
antibodi
rais
recombin
target
variabl
epitop
also
recogn
parasit
surfac
wherea
mani
antibodi
target
conserv
epitop
recogn
parasit
weakli
figur
togeth
data
impli
least
conserv
epitop
within
may
mask
conform
interact
adopt
antigen
parasit
surfac
structur
basi
mask
recent
character
case
one
epitop
murin
monoclon
antibodi
mab
recogn
epitop
conserv
region
bind
recombin
peptid
high
affin
yet
fail
recogn
parasit
region
includ
epitop
bind
lipid
adopt
amphipath
helic
conform
expect
heavili
popul
parasit
given
parasit
helic
conform
incompat
conform
recogn
reveal
crystallographi
figur
b
moreov
epitop
lost
recombin
protein
tether
lipid
indic
interact
lipid
accompani
conform
chang
suffici
account
observ
mask
epitop
parasit
surfac
explor
impact
lipid
conjug
domain
shorter
construct
residu
consist
conserv
region
nmr
data
suggest
unstructur
solut
conform
properti
region
ident
nmr
studi
also
indic
mani
residu
interact
lipid
includ
epitop
recogn
region
specif
monoclon
antibodi
mab
contrast
region
howev
indic
stabl
helic
conform
within
nonetheless
antigen
alter
comparison
recombin
peptid
figur
importantli
also
appear
bind
pattern
specif
mab
antigen
figur
consist
mab
parasit
lysat
thu
lipid
tether
appear
alter
antigen
state
construct
render
similar
antigen
parasit
surfac
base
vaccin
may
therefor
provid
effect
antibodi
respons
similar
mask
potenti
protect
epitop
seen
malaria
antigen
csp
although
repetit
sequenc
csp
long
focu
vaccin
develop
effort
recent
studi
identifi
epitop
within
conserv
region
appear
contribut
protect
respons
csp
context
natur
immun
antibodi
act
synergist
antibodi
target
csp
cours
parasit
develop
within
mosquito
subsequ
migrat
human
host
liver
csp
undergo
proteolyt
process
essenti
establish
infect
proteolysi
expos
otherwis
cryptic
epitop
region
csp
indic
conform
chang
appear
involv
interact
within
csp
turn
determin
access
natur
interact
associ
conform
chang
remain
larg
obscur
light
efficaci
antibodi
target
possibl
also
epitop
like
better
understand
interact
facilit
design
improv
vaccin
construct
disord
protein
typic
adopt
structur
interact
bind
partner
describ
nonetheless
case
signific
disord
persist
interact
give
rise
known
fuzzi
interact
becom
increasingli
clear
fuzzi
interact
modul
function
disord
protein
sever
differ
way
particular
transient
interact
involv
disord
region
flank
structur
defin
bind
site
modul
affin
disord
protein
recogn
bind
extent
interact
modul
antibodi
recognit
disord
antigen
remain
larg
unexplor
recent
character
one
exampl
suggest
modul
feasibl
possibl
quit
gener
mab
introduc
recogn
conserv
epitop
near
yet
bind
two
allel
form
affin
differ
approxim
five
nmr
experi
provid
evid
transient
interact
resolv
crystal
structur
involv
variabl
residu
distal
structur
defin
epitop
transient
fuzzi
interact
thu
appear
modul
specif
render
antibodi
somewhat
spite
conserv
natur
although
gener
effect
remain
establish
appear
origin
larg
interact
occur
almost
inevit
result
high
effect
concentr
disord
region
immedi
flank
structur
defin
expect
similar
fuzzi
interact
may
contribut
antibodi
recognit
mani
disord
antigen
conserv
region
particularli
immunodomin
total
five
mous
mab
abl
recogn
overlap
epitop
span
discuss
antibodi
target
conserv
region
shown
differ
abil
recogn
parasit
figur
mab
abl
bind
parasit
western
blot
immunofluoresc
assay
ifa
whilst
mab
show
significantli
weaker
signal
ifa
bind
western
blot
despit
five
antibodi
recogn
overlap
linear
epitop
close
proxim
region
parasit
surfac
via
gpi
tether
may
influenc
local
conform
make
part
epitop
inaccess
antibodi
bind
understand
conform
epitop
bound
antibodi
afford
good
platform
peptid
vaccin
design
present
immun
system
epitop
access
parasit
surfac
whilst
remov
distract
sequenc
effici
specif
immun
respons
may
elicit
recent
crystal
structur
fv
bound
minim
bind
epitop
also
share
solv
upon
antibodi
bind
peptid
epitop
found
adopt
ribbon
conform
character
consecut
overlap
figur
two
epitop
stabil
hydrogen
bond
involv
allow
key
interact
residu
paratop
structur
inform
suggest
strategi
stabil
analogu
epitop
could
optim
use
peptid
vaccin
view
guid
specif
antibodi
respons
toward
epitop
conserv
access
parasit
surfac
thu
like
contribut
broadli
protect
immun
respons
disord
protein
highli
abund
infecti
organ
across
kingdom
life
protein
bona
fide
target
antibodi
respons
context
natur
infect
contrast
view
disord
antigen
fail
elicit
effect
antibodi
clear
play
import
role
protect
antigen
rang
diseas
tabl
epitop
disord
antigen
typic
short
linear
epitop
complex
conform
epitop
domin
order
antigen
disord
antigen
well
suit
target
peptid
vaccin
despit
potenti
promis
approach
care
consider
must
paid
context
target
epitop
recogn
immun
system
conform
antigen
properti
disord
antigen
strongli
modul
interact
nativ
parasit
context
vaccin
formul
mismatch
parasit
vaccin
context
probabl
contribut
failur
number
vaccin
use
long
peptid
vaccin
formul
potenti
incorpor
sever
protect
epitop
within
nativ
sequenc
may
offer
one
strategi
address
potenti
effect
approach
defin
structur
disord
peptid
epitop
bound
cognat
antibodi
use
structur
inform
basi
design
peptid
structur
stabil
end
rang
avail
strategi
stabil
conform
synthet
peptid
repres
clear
advantag
peptid
vaccin
approach
futur
develop
area
enabl
stabil
wider
rang
peptid
conform
limit
perturb
residu
essenti
antibodi
bind
serv
broaden
scope
strategi
clear
target
vaccin
develop
strategi
describ
requir
detail
understand
function
determin
immun
protect
specif
antigen
epitop
respons
mediat
function
well
understood
pathogen
less
studi
immunolog
complex
pathogen
inform
may
still
emerg
context
new
strategi
profil
immunolog
respons
identif
correl
immun
repres
welcom
advanc
promis
allow
vaccin
develop
diseas
effect
vaccin
current
exist
